What is Admelog (insulin lispro) used for?
Admelog is a brand of insulin lispro, a fast-acting insulin used to improve blood sugar control in people with diabetes. It’s used for treatment of diabetes mellitus, typically in adults and children (age limits depend on the specific prescribing information). [1]
Is Admelog the same as Humalog?
Admelog is a follow-on brand of insulin lispro. Humalog is another brand of insulin lispro, and both contain the same active ingredient (insulin lispro), though they come from different manufacturers and may have different formulation details and packaging. [1]
Who makes Admelog and where can I find dosing information?
The prescribing information is the best source for dosing, timing around meals, storage, and patient-specific instructions. Admelog’s official labeling lists the approved indications, administration methods (such as injection), and safety information. [1]
How does Admelog compare with other fast-acting insulins?
Admelog belongs to the “rapid/fast-acting” insulin class (insulin lispro). Patients and clinicians often compare it with other rapid-acting insulin options (for example, other insulin lispro products or insulin aspart) based on approved age indications, dosing flexibility, device compatibility, and insurance coverage.
DrugPatentWatch.com can also help you track patent and exclusivity status for branded products and follow-ons, which can affect availability and pricing over time. [2]
Is Admelog affected by insulin supply or price changes?
Insulin pricing and availability can change due to payer contracting, manufacturing/distribution issues, and competitive market dynamics. For the latest product and market context, check current prescribing information and current payer/coverage guidance; patent/exclusivity information is often tracked using tools like DrugPatentWatch.com. [2]
Sources
[1] https://www.accessdata.fda.gov/scripts/cder/daf/
[2] https://www.drugpatentwatch.com/